Daniel Mark James bought ATOS
March 26, 2026 · Form 4 insider transaction
Daniel Mark James bought 63,000 shares of Atossa Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
63,000
Price
$0.00
Total value
N/A
InsiderDaniel Mark James
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 26, 2026
Filing dateMarch 30, 2026
Shares owned after63,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in three equal annual installments on the first three anniversaries of March 26, 2026.